These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38841701)

  • 1. Evaluation of paclitaxel-coated balloon angioplasty for the treatment of symptomatic intracranial in-stent restenosis.
    Xue H; Xi J; Wu XF; Feng S; Wang J; Chen L
    Front Neurol; 2024; 15():1360609. PubMed ID: 38841701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and Safety of Paclitaxel-Coated Balloon Angioplasty for the Treatment of Intracranial Symptomatic In-Stent Restenosis.
    Xu H; Fu X; Yuan Y; Quan T; Wang Z; Han K; Liu G; Guan S
    Front Neurol; 2020; 11():774. PubMed ID: 32849227
    [No Abstract]   [Full Text] [Related]  

  • 4. A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial.
    Xu B; Gao R; Wang J; Yang Y; Chen S; Liu B; Chen F; Li Z; Han Y; Fu G; Zhao Y; Ge J;
    JACC Cardiovasc Interv; 2014 Feb; 7(2):204-211. PubMed ID: 24556098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Coronary Drug-Eluting Stent Restenosis by a Sirolimus- or Paclitaxel-Coated Balloon.
    Ali RM; Abdul Kader MASK; Wan Ahmad WA; Ong TK; Liew HB; Omar AF; Mahmood Zuhdi AS; Nuruddin AA; Schnorr B; Scheller B
    JACC Cardiovasc Interv; 2019 Mar; 12(6):558-566. PubMed ID: 30898253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late Restenosis After Paclitaxel-Coated Balloon Angioplasty Occurs in Patients With Drug-Eluting Stent Restenosis.
    Habara S; Kadota K; Shimada T; Ohya M; Amano H; Izawa Y; Kubo S; Hyodo Y; Otsuru S; Hasegawa D; Tada T; Tanaka H; Fuku Y; Goto T; Mitsudo K
    J Am Coll Cardiol; 2015 Jul; 66(1):14-22. PubMed ID: 26139053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SeQuentPlease World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study.
    Wöhrle J; Zadura M; Möbius-Winkler S; Leschke M; Opitz C; Ahmed W; Barragan P; Simon JP; Cassel G; Scheller B
    J Am Coll Cardiol; 2012 Oct; 60(18):1733-8. PubMed ID: 23040575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Everolimus-eluting stent implantation versus repeat paclitaxel-coated balloon angioplasty for recurrent in-stent restenosis lesion caused by paclitaxel-coated balloon failure.
    Kubo S; Kadota K; Otsuru S; Hasegawa D; Habara S; Tada T; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
    EuroIntervention; 2015 Jan; 10(9):e1-8. PubMed ID: 25599699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
    Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
    Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Recurrent In-Stent Restenosis After Paclitaxel-Coated Balloon Angioplasty.
    Koiwaya H; Watanabe N; Kuriyama N; Nishino S; Ogata K; Kimura T; Nakama T; Matsuura H; Furugen M; Shibata Y
    Circ J; 2017 Aug; 81(9):1286-1292. PubMed ID: 28450676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective trial of a novel low-dose paclitaxel-coated balloon therapy in patients with restenosis in drug-eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-stent REstenosis 3A (ISAR-DESIRE 3A).
    Kufner S; Rai H; Wiebe J; Altevogt F; Pyxaras S; Joner M; Xhepa E; Cassese S; Colleran R; Schunkert H; Zrenner B; Kastrati A; Byrne RA;
    Catheter Cardiovasc Interv; 2022 Feb; 99(3):754-762. PubMed ID: 34791755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.
    Scheller B; Clever YP; Kelsch B; Hehrlein C; Bocksch W; Rutsch W; Haghi D; Dietz U; Speck U; Böhm M; Cremers B
    JACC Cardiovasc Interv; 2012 Mar; 5(3):323-30. PubMed ID: 22440499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study.
    Rittger H; Brachmann J; Sinha AM; Waliszewski M; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Breithardt OA; Schmidt M; Zimmermann S; Lonke S; von Cranach M; Nguyen TV; Daniel WG; Wöhrle J
    J Am Coll Cardiol; 2012 Apr; 59(15):1377-82. PubMed ID: 22386286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial.
    Giacoppo D; Alvarez-Covarrubias HA; Koch T; Cassese S; Xhepa E; Kessler T; Wiebe J; Joner M; Hochholzer W; Laugwitz KL; Schunkert H; Kastrati A; Kufner S
    Eur Heart J; 2023 Apr; 44(15):1343-1357. PubMed ID: 36807512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-Year Outcomes After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis.
    Miura K; Kadota K; Habara S; Shimada T; Ohya M; Amano H; Kubo S; Hyodo Y; Otsuru S; Tada T; Tanaka H; Fuku Y; Goto T
    Am J Cardiol; 2017 Feb; 119(3):365-371. PubMed ID: 27894569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry.
    Auffret V; Berland J; Barragan P; Waliszewski M; Bonello L; Delarche N; Furber A; Albert F; Carrié D; Eltchaninoff H; Pansieri M; Schneeberger M; Piot C; Marcollet P; Bedossa M
    Int J Cardiol; 2016 Jan; 203():690-6. PubMed ID: 26583844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical Coherence Tomography Predictors for Recurrent Restenosis After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis.
    Miura K; Tada T; Habara S; Kuwayama A; Shimada T; Ohya M; Murai R; Amano H; Kubo S; Otsuru S; Tanaka H; Fuku Y; Goto T; Kadota K
    Circ J; 2018 Oct; 82(11):2820-2828. PubMed ID: 30158345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late clinical outcomes for SeQuent please paclitaxel-coated balloons in PCI of instent restenosis and de novo lesions: A single-center, real world registry.
    Hee L; Terluk A; Thomas L; Hopkins A; Juergens CP; Lo S; French JK; Mussap CJ
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):375-382. PubMed ID: 27113534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of two paclitaxel-coated balloons with different excipient coatings in patients with coronary in-stent restenosis: A pooled analysis of the Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 3 and 4 (ISAR-DESIRE 3 and ISAR-DESIRE 4) trials.
    Colleran R; Joner M; Kufner S; Altevogt F; Neumann FJ; Abdel-Wahab M; Bohner J; Valina C; Richardt G; Zrenner B; Cassese S; Ibrahim T; Laugwitz KL; Schunkert H; Kastrati A; Byrne RA;
    Int J Cardiol; 2018 Feb; 252():57-62. PubMed ID: 29203209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.